ScholarLens Back to search
2017•Ginecologia roOpen access

Mono ovulation in women with polycystic ovary syndrome - outcomes of different therapies

Lucia Luchian, Bogdan Luchian, Bogdan Marinescu

Open full text 0 citations

Abstract

Ovulation induction is the first line of treatment for in­fer­ti­lity in women diagnosed with polycystic ovary syndrome and with no other cause of infertility. Clomi­phene citrate is the most frequently used pharmacological agent. A pros­pective study was conducted to evaluate different ovu­lation induction agents (clomiphene citrate, letrozole, re­com­binant FSH) outcomes in 60 patients diagnosed with this syndrome. The study showed similar re­sults from letrozole and clomiphene citrate in ovulation in­duction and pregnancy, but recombinant FSH had the best results.

About this research paper

What this paper is about

Ovulation induction is the first line of treatment for in­fer­ti­lity in women diagnosed with polycystic ovary syndrome and with no other cause of infertility. Clomi­phene citrate is the most frequently used pharmacological agent. A pros­pective study was conducted to evaluate different ovu­lation induction agents (clomiphene citrate, letrozole, re­com­binant FSH) outcomes in 60 patients diagnosed with this syndrome. The study showed similar re­sults from letrozole and clomiphene citrate in ovulation in­duction and pregnancy, but recombinant FSH had the best results.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ovulation induction is the first line of treatment for in­fer­ti­lity in women diagnosed with polycystic ovary syndrome and with no other cause of infertility. Clomi­phene citrate is the most frequently used pharmacological agent. A pros­pective study was conducted to evaluate different ovu­lation induction agents (clomiphene citrate, letrozole, re­com­binant FSH) outcomes in 60 patients diagnosed with this syndrome. The study showed similar re­sults from letrozole and clomiphene citrate in ovulation in­duction and pregnancy, but recombinant FSH had the best results.

Key concepts: Polycystic ovary, Ovulation induction, Letrozole, Infertility, Ovulation, Medicine, Gynecology, Pregnancy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Mono ovulation in women with polycystic ovary syndrome - outcomes of different therapies — Research Paper | ScholarLens